Elevated serum levels of pantropic p53 proteins in chromium workers

被引:27
作者
Hanaoka, T [1 ]
Yamano, Y [1 ]
Katsuno, N [1 ]
Kagawa, J [1 ]
Ishizu, S [1 ]
机构
[1] TOKYO WOMENS MED COLL, DEPT HYG & PUBL HLTH, TOKYO 162, JAPAN
关键词
biomarkers; environmental carcinogenesis; molecular epidemiology; risk assessment;
D O I
10.5271/sjweh.176
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objectives This study investigated the possibility of applying serum pantropic p53 proteins in molecular epidemiologic studies, as a biomarker of environmental carcinogenesis. The serum levels of pantropic p53 proteins were determined in workers with past exposure to hexavalent chromium compounds. Methods Thirty-one male workers occupationally exposed to hexavalent chromium compounds in the production of chromium compounds for 0 to 23 years served as the exposed group. The referents were 10 volunteers without work-related exposure to chemicals. In the determination of pantropic p53 proteins, commercially available kits for enzyme-linked immunosorbent assay were used which quantitatively detected both mutant and wild-type human p53 proteins. Results The serum level of pantropic p53 proteins was in the range of 116.4 to 1122.6 pg/ml for the exposed workers and of 117.4 to 305.8 pg/ml for the referents. Nineteen percent of the exposed workers had a high p53 protein level (6 out of 31) when compared with the referents. All but 1 of the 6 workers had been occupationally exposed to chromium compounds for more than 11 years. Two of the 3 workers with a past history of lung cancer also showed high levels. Conclusions Our findings confirm that the application of p53 proteins as a biomarker of environmental carcinogenesis merits further exploration.
引用
收藏
页码:37 / 40
页数:4
相关论文
共 28 条
[1]  
[Anonymous], 1990, IARC MON EV CARC RIS
[2]  
BRANDTRAUF PW, 1990, J SOC OCCUP MED, V40, P11
[3]  
BRANDTRAUF PW, 1988, BRIT J IND MED, V45, P689
[4]  
BRANDTRAUF PW, 1989, J SOC OCCUP MED, V39, P141
[5]  
CHIBA I, 1990, ONCOGENE, V5, P1603
[6]  
DAMME KV, 1995, J OCCUP ENVIRON MED, V37, P91
[7]   A GENETIC MODEL FOR COLORECTAL TUMORIGENESIS [J].
FEARON, ER ;
VOGELSTEIN, B .
CELL, 1990, 61 (05) :759-767
[8]   THE P53 PROTO-ONCOGENE CAN ACT AS A SUPPRESSOR OF TRANSFORMATION [J].
FINLAY, CA ;
HINDS, PW ;
LEVINE, AJ .
CELL, 1989, 57 (07) :1083-1093
[9]  
FONTANINI G, 1994, INT J ONCOL, V5, P553
[10]   USE OF CHEMICAL, BIOCHEMICAL, AND GENETIC-MARKERS IN CANCER-EPIDEMIOLOGY AND RISK ASSESSMENT [J].
HEMMINKI, K .
AMERICAN JOURNAL OF INDUSTRIAL MEDICINE, 1992, 21 (01) :65-76